MannKind adds to diabetes treatment portfolio with $10M acquisition
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen shares jump after company announces buyback plan and long-term projections
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
For ImmPact’s new CEO, Camarillo biotech company checked all the boxes
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen reports Q2 earnings decline
Amgen saw a 73% decline in net earnings in the second quarter of 2021, the company announced Aug. 3. Thousand Oaks-based Amgen, one of the world’s largest biotechnology companies, reported earnings per share of 81 cents for the quarter ended June 30, down from $3.05 per share in the same quarter last year. According to Read More →
Arcutis shares flat on earnings report
Arcutis Biotherapeutics saw a steep rise in operating expenses resulting in a 183% increase in net loss compared to the previous year when the company revealed its fourth quarter and full-year financial results on Feb. 16. However, the Westlake Village biotech company is still in high spirits, as the company is in a “strong financial Read More →
Conejo Valley braces for Amgen layoffs
Biotech giant Amgen is in the process of laying off hundreds of workers, including as many as 100 at its Thousand Oaks headquarters. According to a spokesperson for the company, approximately 500 workers will be let go beginning April 2, with fewer than 20% of those workers located in Thousand Oaks. Amgen employs around 22,000 Read More →
Amgen to lay off hundreds, including in Thousand Oaks
Biotech giant Amgen is in the process of laying off hundreds of workers, including as many as 100 at its Thousand Oaks headquarters. According to a spokesperson for the company, approximately 500 workers will be let go beginning April 2. Less than 20% of those workers are located in Thousand Oaks. Amgen employs around 22,000 Read More →
